Epilepsy Trial, Recruiting (NCT06598189)

Epilepsy Trial, Recruiting NCT06598189 Sponsor: Felicia Chu Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06598189 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older.
People who have been admitted to the UMass Memorial Epilepsy Monitoring Unit for long-term video-EEG monitoring as part of their regular epilepsy care, for either focal or generalised epilepsy.
People who are willing to wear a small wearable device during the study.
People who are able to give their informed consent to take part.

Who may not be able to join:

People who already wear a device in or around the ear, such as a hearing aid.
People who are unable or unwilling to give informed consent.
People who have skin irritation in the area where the device would be placed.
People who have electrodes placed inside their skull (intracranial electrodes) as part of their monitoring.
People who are currently imprisoned.
People who have been assessed as having a cognitive impairment (confirm with trial site).
People who are pregnant.
Children and teenagers aged 0 to 17.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Felicia Chu, MD, UMass Neurology Department

Phone: 508-856-3939

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06598189

Sponsor: Felicia Chu

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 508-856-3939

More information: https://clinicaltrials.gov/study/NCT06598189

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older.
People who have been admitted to the UMass Memorial Epilepsy Monitoring Unit for long-term video-EEG monitoring as part of their regular epilepsy care, for either focal or generalised epilepsy.
People who are willing to wear a small wearable device during the study.
People who are able to give their informed consent to take part.

Who may not be able to join:

People who already wear a device in or around the ear, such as a hearing aid.
People who are unable or unwilling to give informed consent.
People who have skin irritation in the area where the device would be placed.
People who have electrodes placed inside their skull (intracranial electrodes) as part of their monitoring.
People who are currently imprisoned.
People who have been assessed as having a cognitive impairment (confirm with trial site).
People who are pregnant.
Children and teenagers aged 0 to 17.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Felicia Chu

Registry

ClinicalTrials.gov

Start date

3 April 2025

Est. completion

1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Seizure Recording Criteria 1; Seizure Recording Criteria 2; Seizure Recording Criteria 3; Data Interpretation; Seizure Accuracy/Prediction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov